Figure 2 from A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer – The MONEO Study
<p>Tissue biomarker analyses and the VIGex score. <b>A,</b> Immune tumor contexture of the basal samples and surgical specimens in patients with MPR (<i>n</i> = 8) and without MPR (<i>n</i> = 25). <b>B,</b> Gene expression profile on surgical spe...
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| 出版: |
2025
|
| 主题: | |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|